COVID-19: Canada recommends mRNA vaccine as second jab for people whose first dose was the AstraZeneca vaccine
COVID-19 Vaccine: Canada has till date approved only Moderna and Pfizer-BioNTech's mRNA jabs for use.18-06-2021
18-06-2021
Another vaccine to be rolled out soon! Serum plans to launch Covovax by Sept
Novavax's COVID-19 vaccine has shown 90.4 per cent efficacy in Phase 3 trials, putting it in the same league as other vaccines including Pfizer-BioNTech (91.3 per cent) and Moderna (90 per cent)17-06-2021
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received requests for issue of duplicate Share Certificate(s) from the Shareholders.16-06-2021
Pfizer, AstraZeneca Covid jabs highly effective against Delta variant
The analysis suggests that the Pfizer-BioNTech vaccine is 96 per cent effective against hospitalisation after two doses15-06-2021
Pfizer Ltd - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received request for issue of duplicate Share Certificate(s) from the Shareholder.14-06-2021
COVID-19 | CDC looking into reports of heart inflammation after Pfizer, Moderna vaccine 2nd jab
As of May 31, the agency had 275 preliminary reports of such inflammation in 16- to 24-year-olds, CDC's Dr Tom Shimabukuro told a government vaccine meeting on Thursday. That's out of more than 12 million second-dose injections of the vaccines.11-06-2021
US extends expiration dates for Johnson & Johnson Covid vaccine by 6 weeks
Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks. The company said a Food and Drug Administration review concluded the shots remain safe and effective for at least 4 1/2 months. In February, the FDA originally authorised J&J's vaccine for up to three months when stored at normal refrigeration levels. Thursday's announcement comes after state officials warned that many doses in storage would expire before the end of the month. Vaccine expiration dates are based on information from drugmakers on how long the shots stay at the right strength. J&J said the FDA added six weeks based on data from ongoing studies assessing the vaccine's stability. The FDA has been reviewing expiration dates on all three U.S. authorised vaccines as companies have continued to test batches in the months since the shots first rolled out. The vaccines from Pfizer and Moderna, authorized in December, have a...11-06-2021
Asia welcomes United States vaccine donations amid cold storage worries
Health officials and experts in Asia have welcomed US plans to share 500 million more doses of the Pfizer vaccine with the developing world10-06-2021
Two doses of Pfizer, Moderna vaccines cut infection risk by 91%: US CDC
Taking two doses of the Pfizer-BioNTech and Moderna's mRNA-based vaccines, authorised by the Food and Drug Administration, can reduce the risk of coronavirus infection by 91 per cent08-06-2021
Pfizer supports deployment of oxygen and ICU beds in Delhi, Mumbai
Around 10 per cent of these beds have been set up to meet the requirements of Covid-19 paediatric patients.08-06-2021